Jazz Pharmaceuticals plc — Director's Dealing 2015

Sep 25, 2015

SEC Form 4/A — Form 4/A

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-08-07

Reporting Person: BERNS PAUL L (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	4502	Direct

Footnotes

F1: This Form 4 amends the Form 4 filed on August 11, 2015. Due to a clerical error, the amount of securities beneficially owned by the Reporting Person following the Reported Transactions in Table I was overstated by 1,087 shares.